Inovio Pharma (INO) Reports Q2 Loss of $0.83/sh
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.22 --0%
EPS Growth %: +60.7%
Financial Fact:
Grant and miscellaneous revenue: 9.41M
Today's EPS Names:
CRMT, PKE, More
EPS Growth %: +60.7%
Financial Fact:
Grant and miscellaneous revenue: 9.41M
Today's EPS Names:
CRMT, PKE, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q2 EPS of ($0.83), versus ($0.30) reported last year. Revenue for the quarter came in at $237 thousand, versus $135.7 thousand reported last year.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Ryanair (RYA:ID) (RYAAY) PT Raised to EUR32.50 at Bernstein SocGen Group, Best Idea for the third quarter of 2026
- Guardant Health (GH) PT Raised to $190 at BofA Securities
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
